SCHEMBL7207560

SCHEMBL7207560

COc1ccc(S(=O)(=O)C(CCO)c2ccccc2)cc1

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP13 P45452 5/20 0.75
PDE4A P27815 8/20 0.64
PDE4B Q07343 8/20 0.64
PDE4C Q08493 8/20 0.64
PDE4D Q08499 8/20 0.64
MMP2 P08253 6/20 0.64
MMP3 P08254 6/20 0.64
NPC1 O15118 3/20 0.59
ALDH1A1 P00352 3/20 0.59
RAB9A P51151 2/20 0.59
SMN1; SMN2 Q16637 2/20 0.59
TDP1 Q9NUW8 1/20 0.59
LMNA P02545 2/20 0.57
MAPT P10636 2/20 0.57
MMP1 P03956 9/20 0.51
KMT2A Q03164 2/20 0.50
MMP9 P14780 1/20 0.48
KDM4E B2RXH2 1/20 0.47
MEN1 O00255 1/20 0.47
GAA P10253 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7208439 0.86 MMP13 (1.00) MMP13PDE4APDE4BPDE4CPDE4D
SCHEMBL7407018 0.84 MMP13 (0.72) MMP13PDE4APDE4BPDE4CPDE4D
SCHEMBL15617705 0.82 NPC1 (0.69) MMP13PDE4APDE4BPDE4CPDE4D
SCHEMBL7207785 0.81 PDE4A (0.77) MMP13PDE4APDE4BPDE4CPDE4D
SCHEMBL29160472 0.80 ALDH1A1 (0.90) MMP13PDE4APDE4BPDE4CPDE4D
SCHEMBL6823156 0.79 MMP2 (1.00) MMP13PDE4APDE4BPDE4CPDE4D
SCHEMBL7207040 0.78 MMP1 (0.76) MMP13PDE4APDE4BPDE4CPDE4D
SCHEMBL28745216 0.77 NPC1 (0.45) MMP13PDE4APDE4BPDE4CPDE4D
SCHEMBL7207685 0.77 MMP13 (0.51) MMP13MMP2MMP3MMP1MMP9
SCHEMBL6928548 0.75 MMP13 (0.56) MMP13PDE4APDE4BPDE4CPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0939628-B1 THIOL SULFONE METALLOPROTEASE INHIBITORS MONSANTO CO (US) 2003-03-05 EP disclosed
US-6013649-A BOND DISORDERS; AUTOIMMUNE DISEASES; ANTITUMOR AGENTS MONSANTO COMPANY (US) 2000-01-11 US disclosed